Bromodomain inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bromodomain inhibitor (unspecified), covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas [Phase 2]